Track 3 platforms and get the weekly governance digest. No credit card required.
This page describes what the document states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability may vary by jurisdiction. Methodology
This document is Perplexity AI's enterprise terms of service governing paid access to Perplexity Enterprise Pro and Enterprise Max by organizations, covering usage rights, data handling, fees, confidentiality, and liability. The agreement explicitly prohibits Perplexity from using Customer Content, including queries and outputs, to train or improve AI models, and assigns ownership of both inputs and outputs to the Customer. The agreement also authorizes Perplexity to collect and use anonymized Usage Data, including metadata and performance analytics, for any lawful purpose without remuneration to the Customer.
This Agreement governs Customer access to and use of Perplexity Enterprise Pro and Perplexity Enterprise Max, establishing a binding contract between the subscribing organization and Perplexity AI, Inc., effective upon account access or acceptance. The agreement states that Customer retains ownership of Input and Output, that Perplexity expressly prohibits use of Customer Content to train or fine-tune AI models, that fees are nonrefundable and subject to a 1.5% monthly late charge, and that Perplexity may unilaterally update agreement terms with notice, with continued use constituting acceptance. The model-training prohibition in Section 1.3.3 and the express Output ownership assignment in Section 1.3.1 are operationally notable for enterprise AI procurement; however, the agreement disclaims all implied warranties, caps Perplexity's aggregate liability at fees paid in the prior 12 months, and excludes consequential damages, which are provisions that compliance teams should evaluate against their organization's risk tolerance and applicable law. The agreement engages GDPR and CCPA through an incorporated Data Processing Addendum, references HIPAA in Section 5.2 by prohibiting processing of Protected Health Information without a Business Associate Agreement, and implicates U.S. export control frameworks under Section 10.9; the applicability and enforceability of specific provisions will depend on Customer jurisdiction and the content of the separately published DPA.
Institutional analysis available with Compliance
Regulatory exposure by statute, material risk assessment, vendor due diligence action items, and enforcement precedent. Available on Compliance.
Get Compliance1 important change detected
2 versions captured · Last updated: May 2026
Every distinct legal provision identified in this document. Featured provisions appear above with analysis.
Monitoring
Perplexity AI has updated this document before.
Monitor includes same-day alerts, structured change summaries, and monitoring for up to 25 platforms.
Compliance Governance Intelligence
Need provision-level monitoring and regulatory mapping?
Compliance includes governance timelines, compliance memos, audit-ready analysis, and full provision tracking.
Get ComplianceCross-platform context
See how other platforms handle All Payments Are Nonrefundable and similar clauses.
Compare across platforms →Governance Monitoring
Structured alerts for policy changes, governance events, and provision updates across 318+ platforms.